ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Avon, NABCO Accepting Grant Applications For Community-Based Breast Cancer Programs

June 9, 1995

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

Funding opportunities listed.

October 17, 2003

NCI contract Award

August 1, 1997

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999